NewSr. Director, Supply Chain Transformation Fluence Energy IncSr. Director, Supply Chain TransformationAlpharetta, GAThis role serves as a strategic advisor, execution subject matter expert, and transformation leader, partnering with executive leadership and cross-functional teams to identify opportunities, develop transformation roadmaps, drive organizational change, and ensure successful execution of critical initiatives. The Senior Director of Supply Chain Transformation is responsible for driving strategic transformation initiatives across the organization by aligning business processes, systems, people, and operating models for the Global Innovation and Development group to support growth and operational excellence across Fluence Energy.
NewDirector, Project Development - Manufacturing Facility Design-Build Barry-Wehmiller CompaniesDirector, Project Development - Manufacturing Facility Design-BuildAtlanta, GADirector, Project Development – Manufacturing Design-BuildApplylocations: Atlanta, GA: Philadelphia, PA: Fort Worth, TX: Boston, MA: St. Louis, MOtime type: Full timeposted on: Posted Todayjob requisition id: R021970**About Us:**BW Design Group is a fully integrated architecture, engineering, construction, system integration, and consulting firm committed to helping our clients realize their most critical goals from Strategy to Commercialization. You will be a key member of our Project Development & Planning group — known internally as *"The Accelerator Group"* — partnering with commercial development teams, technical specialists, and subject matter experts to bridge the gap between opportunity pursuit and project delivery, ensuring the highest quality front-end planning and project development solutions reach our clients with consistency and accuracy.**What
NewDirector, Brand Marketing Dodge Construction NetworkDirector, Brand MarketingAtlanta, GARemoteDodge Construction Network's compensation and rewards package for full time roles includes a market competitive salary, comprehensive benefits, and, for applicable roles, uncapped variable incentive plans or an annual discretionary performance bonus. Identify and manage key online communities and Reddit threads where we must be active, including the ability to reactively respond to relevant threads and proactively insert our thought leaders when they have relevant insights.
Senior Director, Institutional Valuation Practice JLLSenior Director, Institutional Valuation PracticeAtlanta, GAWhether you've got deep experience in commercial real estate, skilled trades or technology, or you're looking to apply your relevant experience to a new industry, join our team as we help shape a brighter way forward. The IVP partners with sector and geographic specialists to ensure platform consistency and shared resources and is committed to a level of analysis and quality befitting the institutional clientele it serves.
NewCampus Director Art of Problem SolvingCampus DirectorJohns Creek, Georgia$103,425–$106,775 / yearThe AoPS Academy Campus Director at our Johns Creek campus leads a vibrant, dynamic enrichment program where each day brings new opportunities to engage students, mentor instructors, and solve meaningful challenges. Build a culture of instructional excellence in which all instructors continue to grow as educators and ambassadors of the AoPS approach, and exceptionally talented teachers who can engage and challenge our most advanced students are recognized and celebrated.
Director, Project Development Barry-WehmillerDirector, Project DevelopmentAtlanta, GAYou will be a key member of our Project Development & Planning group - known internally as "The Accelerator Group" - partnering with commercial development teams, technical specialists, and subject matter experts to bridge the gap between opportunity pursuit and project delivery, ensuring the highest quality front-end planning and project development solutions reach our clients with consistency and accuracy. By blending people-centric leadership with disciplined operational strategies and purpose-driven growth, Barry-Wehmiller has become a $3 billion organization with nearly 12,000 team members united by a common belief: to use the power of business to build a better world.
Director, Client Development - Food & Beverage + CPG (Design-Build/Epc) Barry-WehmillerDirector, Client Development - Food & Beverage + CPG (Design-Build/Epc)Atlanta, GAThis client-facing growth leadership role blends strategic client alignment with deep technical expertise to expand multi-project initiatives across processing, packaging, utilities, and facility modernization-including hygienic design, cold chain, and regulated food manufacturing environments-in both brownfield and greenfield settings. Operating outside traditional utilization expectations (e.g., billable hours), the role is measured by bookings, margin-aware account growth, delivery performance, and long-term client value-empowering you to focus on high-impact client strategy, pursuit leadership, and capital alignment in an entrepreneurial environment.
Director, Product Design Ministry Brands Holdings, LLC.Director, Product DesignAlpharetta, GAYou'll work closely with cross-functional teams including Product Management, Engineering, and Marketing, and play a central role in ensuring our product design aligns with customer needs, brand values, and evolving AI capabilities. Ministry Brands is a leading provider of SaaS operational management systems, payments platforms, digital engagement tools and background screening solutions for faith-based, non-profit and for-profit organizations.
Field Director, Medical Science Liaisons - East Region US - Obesity And Related Conditions Amgen Inc.Field Director, Medical Science Liaisons - East Region US - Obesity And Related ConditionsAtlanta, GAIn addition to the base salary, Amgen offers a Total Rewards Plan, based on eligibility, comprising of health and welfare plans for staff and eligible dependents, financial plans with opportunities to save towards retirement or other goals, work/life balance, and career development opportunities that may include: A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts. As an organization dedicated to improving the quality of life for people around the world, Amgen fosters an inclusive environment of diverse, ethical, committed and highly accomplished people who respect each other and live the Amgen values to continue advancing science to serve patients.
Product Director, Branded Ingredients - Biotics - H&W - Kennesaw, GA Archer Daniels Midland CoProduct Director, Branded Ingredients - Biotics - H&W - Kennesaw, GAKennesaw, GAWe are committed to attracting and retaining a diverse workforce and create welcoming, truly inclusive work environments - environments that enable every ADM colleague to feel comfortable on the job, make meaningful contributions to our success, and grow their career. With industry-advancing innovations, a complete portfolio of ingredients and solutions to meet any taste, and a commitment to sustainability, we give customers an edge in solving the nutritional challenges of today and tomorrow.
Audit Director Professional Practices, Strategy & PMO Truist Financial CorpAudit Director Professional Practices, Strategy & PMOAtlanta, GA$185,000–$200,000 / yearGeneral Description of Available Benefits for Eligible Employees of Truist Financial Corporation: All regular teammates (not temporary or contingent workers) working 20 hours or more per week are eligible for benefits, though eligibility for specific benefits may be determined by the division of Truist offering the position. Lead team in the design, development, implementation, and continuous improvement of Audit Services' policies, procedures, practices, processes and methodologies to enable a proactive, risk-based audit assurance program for Truist Corporation.
Senior Director, Clinical Biomarker Operations Revolution Medicines, Inc.Senior Director, Clinical Biomarker OperationsRedwood City, CA$244,000–$305,000 / yearThe Opportunity: Revolution Medicines is seeking a strategic and experienced leader to serve as Senior Director, Clinical Biomarker Operations, responsible for leading the operational execution of biomarker and companion diagnostic (CDx) strategies across early- and late-stage clinical development programs. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, CMC Regulatory Revolution Medicines, Inc.Associate Director, CMC RegulatoryRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: As part of our expanding organization, we seek a strategic and hands-on Associate Director, CMC Regulatory who will be responsible for executing CMC regulatory strategies to support clinical development, marketing authorizations, and lifecycle management of RevMed's pipeline compounds/products.
Associate Director, Clinical Operations Compliance & Training Revolution Medicines, Inc.Associate Director, Clinical Operations Compliance & TrainingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Associate Director, Finance Systems - IT BillionToOneAssociate Director, Finance Systems - ITMenlo Park, CA$192,932–$235,806 / yearAdministerand maintain the company's IT General Controls (ITGCs) across in scope financial systems, implementing the ITGC framework, including logical access, change management, and computer operations controls across all in-scope financial systems. This is a senior individual contributor and people-leadership role that sits at the intersection of finance, compliance, and technology-responsible for ensuring our systems infrastructure is scalable, audit-ready, and aligned with the demands of a public company operating under SOX Section 404(b).
Director Of Enterprise Sales Collectly, Inc.Director Of Enterprise SalesSan Francisco, CA$330,000–$390,000 / yearCollectly applies artificial intelligence to automate workflows, accelerate cash flow, and modernize the patient financial experience; enabling healthcare organizations to operate more efficiently and focus on delivering care. This leader will manage a team of experienced Enterprise Account Executives and be responsible for driving predictable revenue performance through stronger pipeline discipline, sharper enterprise deal strategy, and rigorous execution.
Regional Insights And Engagement Director, Lung, Southeast Revolution Medicines, Inc.Regional Insights And Engagement Director, Lung, SoutheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Senior Director, Head Of Transactions & Partnering Revolution Medicines, Inc.Senior Director, Head Of Transactions & PartneringRedwood City, CARemote$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The role partners closely with Business Development leadership and cross-functional stakeholders across Research, Development, Commercial, Finance, Legal, Intellectual Property, and Executive Management to advance high-priority opportunities from initial assessment through successful execution.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines, Inc.Associate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Statistical Programming Revolution Medicines, Inc.Associate Director, Statistical ProgrammingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Position requires 14+ years of Statistical Programming experience with exploratory-stage oncology clinical trials, providing programming support and oversight of one or more clinical programs (early or late phase) within Statistical Programming function.
Director Of IT BillionToOneDirector Of ITUnion City, CA$214,369–$267,962 / yearAt BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne's Fetal Cell Capture Technology.
Executive Director, Computational Systems Biology Revolution Medicines, Inc.Executive Director, Computational Systems BiologyRedwood City, CA$265,000–$331,000 / yearThe individual will lead a team of computational biologists and bioinformaticians focused on acquisition, organization, and analysis of large multi-omics data sets, using both public and proprietary data sources, that will help inform treatment strategies and guide patient stratification for a growing pipeline of RAS(ON) and targeted oncology therapeutics. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Clinical Supply Chain Revolution Medicines, Inc.Executive Director, Clinical Supply ChainRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Sr. Manager / Associate Director, Quality Audits Personalis, IncSr. Manager / Associate Director, Quality AuditsFremont, CA$165,000–$210,000 / yearReporting directly to the Director of Quality Assurance, this individual is responsible for the strategic oversight, design, and execution of the global Internal Audit program, as well as leading the readiness and management of all External Audits (including regulatory inspections and accreditation assessments).The successful candidate will have strong leadership skills and possess extensive experience managing Quality Management Systems (QMS) within highly regulated environments, driving compliance, governance, and continuous improvement across the organization with a high degree of autonomy. Root Cause & Investigation Leadership: Provide expert guidance and lead cross-functional investigation teams in executing comprehensive root cause analyses for CAPAs, deviations, and non-conformances stemming from internal and external audits.
Associate Director, Global Omnichannel Solutions Delivery Revolution Medicines, Inc.Associate Director, Global Omnichannel Solutions DeliveryRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The individual will play a critical role in supporting global expansion by establishing scalable solutions, enabling adoption of global platforms, and ensuring new capabilities, brands, and regions can be added efficiently without rework or fragmentation.
Director, Program Management Revolution Medicines, Inc.Director, Program ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Director, Program Management partners with the Project Team Leader (PTL) on the translation of program strategy into an efficient execution plan; they understand the competitive landscape and clinical context to manage the cross-functional dependencies and connections.
Director, Market Access Analytics And Enablement DanaherDirector, Market Access Analytics And EnablementSunnyvale, CARemote$185,000–$215,000 / yearAssume full ownership of the development, refinement, and implementation of strategy for data analytics and enablement function including: development of market access enablement tools; market insights/trends generation; healthcare coding analyses (diagnosis codes, billing codes, code modifiers, etc.); pricing and fee schedule evaluations; payer coverage dashboards; team dashboards; analytics frameworks; operational tools; and utilization of AI-based tools to inform decision-making and accelerate business outcomes. Success in this position requires an opportunity mindset, strong executive presence, demonstrated leadership capabilities, innovative thinking to drive actionable insights and tools, the ability to communicate complex insights clearly across senior and cross-functional stakeholders, and disciplined execution to meet critical deadlines.
Associate Director, Regulatory Systems Revolution Medicines, Inc.Associate Director, Regulatory SystemsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This individual will serve as the business owner for key regulatory systems and partner closely with Regulatory Affairs, Regulatory Operations, IT, Quality, Clinical, and external vendors to deliver scalable, compliant, and efficient business solutions.
Associate Director, Business Operations Revolution Medicines, Inc.Associate Director, Business OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The role is ideal for a Associate Director -level professional who thrives on execution, can drive several projects in parallel, can navigate a matrix environment, and brings strong project leadership, communication and change management experience.
Director, Clinical Study Management Eikon Therapeutics, Inc.Director, Clinical Study ManagementMillbrae, CA$226,000–$273,000 / yearThis role will require a minimum of 3 days a week of onsite presence (or more as business needs require) in either of our Jersey City, New Jersey or Millbrae, California offices to ensure effective management and high-performance delivery of clinical studies. The Director will manage all aspects of clinical operations study management for assigned Eikon clinical studies, and be responsible for exquisite inhouse execution of all such clinical trials and oversight of requisite clinical vendors.
Senior Director, Head Of Search & Evaluation Revolution Medicines, Inc.Senior Director, Head Of Search & EvaluationRedwood City, CARemote$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Working in close partnership with leaders across Research, Development, Commercial, Corporate Strategy, Portfolio Management, and Executive Management, this individual will lead the company's search and evaluation activities across discovery and clinical-stage opportunities.
Director, Regulatory Affairs Companion Diagnostics (Cdx) Revolution Medicines, Inc.Director, Regulatory Affairs Companion Diagnostics (Cdx)Redwood City, CA$211,000–$264,000 / yearRequired Skills, Experience and Education: Advanced degree or bachelor's degree in life sciences, molecular biology, biomedical engineering, pharmacy, medicine, or related scientific discipline with a minimum of 12+ years of pharmaceutical, biotechnology, diagnostics, or combination product experience, including at least 8 years in Regulatory Affairs supporting companion diagnostics or in vitro diagnostics. This individual will serve as the regulatory lead for companion diagnostic development programs, partnering closely with Clinical Development, Translational Medicine, Biomarker Sciences, Regulatory Science, Commercial, and external diagnostic partners to ensure successful co-development and global registration of therapeutic products and associated companion diagnostics.
Director of Commercial Marketing Mendaera, Inc.Director of Commercial MarketingSan Mateo, CA$190,000–$219,000 / yearDevelop and continuously refine clinical value propositions for each procedure and specialty Focalist competes in—grounded in procedure-level insights and translated into messaging that drives adoption and utilization across physician, care team, and hospital audiences. Develop and execute specialty-level market development programs—peer-to-peer events, case observation programs, symposia, and conference presence—designed to build procedural competency and expand the base of trained, active Focalist users.
Regional Insights And Engagement Director, Northeast Revolution Medicines, Inc.Regional Insights And Engagement Director, NortheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Director, Regulatory Affairs (US Filing Lead) Revolution Medicines, Inc.Director, Regulatory Affairs (US Filing Lead)Redwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, Global Patient Safety Operations Revolution Medicines, Inc.Director, Global Patient Safety OperationsRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Work collaboratively and cross-functionally to ensure timely and accurate completion of expedited and periodic reports (e.g., DSUR, PBRER), aggregate safety reports, and REMS/RMP analyses, and other safety deliverables.
Director, Global Lead, PI And Digital Twin AVEVA Group PlcDirector, Global Lead, PI And Digital TwinSan Leandro, CA$168,900–$281,700 / yearAVEVA's Global Practice and Services organization (700+ engineers, consultants, program managers and solution architects) is looking for a proven practice leader to own and scale our PI Data Infrastructure & Digital Twin delivery practice worldwide. Solution Portfolio and Technical Excellence: Develop comprehensive offerings spanning AVEVA PI DI, AVEVA Predictive Analytics, AVEVA Operations Control, AIM and CONNECT - integrating real-time (OT) and non-real-time (IT) systems at scale.
Associate Director, Quality Validation Revolution Medicines, Inc.Associate Director, Quality ValidationRedwood City, CA$186,000–$233,000 / yearAs a key member of the Quality organization, the Associate Director, Quality Validation partners closely with cross-functional teams within Pharmaceutical Development & Manufacturing (PDM) and external partners to develop and maintain robust validation strategies, support commercial manufacturing and product disposition activities, drive continuous improvement, and ensure consistent execution of validation programs across the global external manufacturing network. The Opportunity: The Associate Director, Quality Validation is responsible for providing strategic quality leadership and oversight of validation programs supporting Drug Substance (DS), Drug Product Intermediate (DPI), Drug Product (DP), packaging, and distribution activities across the company's global network of CDMOs, packaging partners, and suppliers.
Director, Regulatory Affairs - US Filing Lead Revolution Medicines, Inc.Director, Regulatory Affairs - US Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Global Strategic Account Director DanaherGlobal Strategic Account DirectorSan Francisco, CARemote$150,000–$180,000 / yearResolve complex or unusual business problems by applying advanced critical thinking-coordinates company-wide resources to provide comprehensive solutions based on the entire product and services portfolio across Cytiva. The amount and availability of any bonus, commission, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole discretion unless and until paid and may be modified at the Company's sole discretion, consistent with the law.
Senior Director, Compliance Training Revolution Medicines, Inc.Senior Director, Compliance TrainingRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner closely with Learning & Development, Corporate Communications, Legal, HR, regional compliance staff (U.S., Europe, and Asia), and business stakeholders to ensure effective deployment, localization, communication, and reinforcement of training programs.
Associate Director, Revenue Accounting And Finance Revolution Medicines, Inc.Associate Director, Revenue Accounting And FinanceRedwood City, CA$186,000–$233,000 / yearPrepare and analyze monthly product revenue and gross-to-net close activities, including the calculation, recording, and monitoring of gross-to-net accruals and related reserve balances for prompt pay discounts, copay and patient assistance programs, returns, Medicaid, Medicare Part D, 340B, VA/DoD, and other forms of variable consideration. Manage the day-to-day partnership with the external government pricing consultant, including coordinating required data submissions, reviewing government pricing calculations and related outputs, and supporting accuracy and compliance across government channels, including Medicaid, Medicare Part D, 340B, and VA/FSS programs.
Associate Director, Clinical Quality Assurance Revolution Medicines, Inc.Associate Director, Clinical Quality AssuranceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Clinical Data Management Revolution Medicines, Inc.Director, Clinical Data ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Media Director, Programmatic Syneos Health IncAssociate Media Director, ProgrammaticSan Francisco, CATogether we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. Selecting us as an employer secures a career in which you're guaranteed to: Collaborate with passionate problem solvers Partner with the most diverse team of experts in the industry.
NewSenior Director - TeraWave Ground Terminals Blue Origin Enterprises LPSenior Director - TeraWave Ground TerminalsSan Francisco, CA$317,388–$444,342.15 / yearand/or transports placardable amounts of hazardous materials by ground in any vehicle on a public road while in commerce, may be subject to additional Federal Motor Carrier Safety Regulations including: Driver Qualification Files, Medical Certification (obtained before onboarding), Road Test, Hours of Service, Drug and Alcohol Testing, vehicle inspection requirements, CDL requirements (if applicable) and hazardous materials transportation/shipping training. Required for Certain Job Profiles: Drivers who operate Commercial Motor Vehicles with a Gross Vehicle Weight (GVW), Gross Vehicle Weight Rating (GVWR) or combination of power unit and trailer that meets or exceeds 10,001 lbs.
Director, Systems Engineering (Hybrid) CeribellDirector, Systems Engineering (Hybrid)Sunnyvale, CA$216,000–$283,000 / yearThe Ceribell System is a novel, point-of-care electroencephalography ("EEG") platform specifically designed to address the unmet needs of patients in the acute care setting, and is being used in hundreds of community hospitals, large academic facilities and major IDN's across the country. Position Overview: We are seeking a highly technical Director of Systems Engineering to lead the core electrical hardware, systems, and software development of our next-generation products, while providing ongoing systems engineering leadership for our current core products.
Director, Systems Engineering (Hybrid) Ceribell, IncDirector, Systems Engineering (Hybrid)Sunnyvale, CA$216,000–$283,000 / yearThe Ceribell System is a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting, and is being used in hundreds of community hospitals, large academic facilities and major IDN's across the country. Position Overview : We are seeking a highly technical Director of Systems Engineering to lead the core electrical hardware, systems, and software development of our next-generation products, while providing ongoing systems engineering leadership for our current core products.
Director, System Software Engineering - Metropolis Accelerated And Inferencing Software NvidiaDirector, System Software Engineering - Metropolis Accelerated And Inferencing SoftwareSanta Clara, CAYou bring strong intuition for modern architectures (e.g., transformers, diffusion, and VLMs); deep experience tuning on NVIDIA GPUs (kernels, memory, and latency/efficiency trade-offs)/SOCs; and a proven record of delivering robust, low-latency inference at scale. Drive strategic implementations of TensorRT, VLLM, and other accelerated frameworks for inference solutions for Edge and Enterprise devices: Lead Accelerated Computing efforts and solutions for key Metropolis verticals.
NewSenior Director, US Compliance Revolution Medicines, Inc.Senior Director, US ComplianceRedwood City, CA$244,000–$305,000 / yearAreas of focus include: Serve as the strategic compliance advisor to Commercial, Medical Affairs, Market Access, Patient Services, and other field-facing functions by proactively identifying compliance risks, enabling compliant business solutions, and embedding compliance into key business decisions throughout commercialization and product launch. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.